Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03067675 · ClinicalTrials.gov registry record
Triton Reference Database
A clinical trial of Healthy Eyes, sponsored by Topcon Corporation.
- Completed
- Registry status
- 500
- Enrollment target
- 6
- Study locations
NCT03067675: Completed study of Healthy Eyes, sponsored by Topcon Corporation.
NCT03067675 is a study of Healthy Eyes that has completed, run by Topcon Corporation. The registered enrollment target is 500 participants. The trial reports 6 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03067675, a study of Healthy Eyes, has completed, sponsored by Topcon Corporation.
- COMPLETED
- Registry status
- 500 participants
- Enrollment target
- 6
- Study locations
Study Summary
The objective of this study is to collect OCT measurement data on normal healthy eyes.
Primary Outcome
The thickness of the macula layer
Conditions Studied
Interventions
- DEVICE Topcon DRI OCT Triton (plus)
Study Locations (6)
California
- Southern California College of Optometry - Anaheim
- Accessoreyes Optometry - Pasadena
New York
- New York VA - Jamaica
- Stat University of New York College of Optometry - New York
Illinois
- Illinois College of Optometry - Chicago
Minnesota
- Fischer Laser Eye Center - Willmar
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 2017-03-01 |
| Est. Completion | 2017-09-30 |
What the finished NCT03067675 record still lists
NCT03067675 is an observational study that tracks outcomes without assigning an intervention. The registered 500 participants enrollment target is mid-sized for trials with a published cap.
The record links to 1 condition, with Healthy Eyes appearing as the primary indexed condition, and to 1 intervention - of which Topcon DRI OCT Triton (plus) is the first listed.
NCT03067675 lists 6 locations in 4 states (California, New York, Illinois).
Frequently Asked Questions
What is clinical trial NCT03067675 about?
NCT03067675 is a clinical study titled "Triton Reference Database". The objective of this study is to collect OCT measurement data on normal healthy eyes.
What is the current status of trial NCT03067675?
This trial is currently completed. The enrollment target is 500 participants. The study started on 2017-03-01. Estimated completion is 2017-09-30.
What conditions does trial NCT03067675 study?
This clinical trial studies the following conditions: Healthy Eyes.
What interventions are being tested in trial NCT03067675?
The interventions under investigation include: Topcon DRI OCT Triton (plus) (DEVICE).
Who is sponsoring clinical trial NCT03067675?
This trial is sponsored by Topcon Corporation, which has 8 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03067675 being conducted?
This trial has 6 study locations across California, Illinois, Minnesota, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Healthy Eyes
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001230 · 500 participants
Host Response to Infection and Treatment in Filarial Diseases
- NCT00001529 · 500 participants
Improved Methods of Cell Selection for Bone Marrow Transplant Alternatives
- NCT00697411 · 500 participants
Study of Selected X-Linked Disorders: Aicardi Syndrome
- NCT00903110 · 500 participants
Global Patient Registry to Monitor Long-term Safety and Effectiveness of Increlex® in Children and Adolescents With Severe Primary Insulin-like Growth Factor-1 Deficiency (SPIGFD).
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI